Some suppliers label it one way, others label it differently
According to prescribing information and the company's safety disclosures, you should not use GLP-1 medications - or should only do so under specialist supervision - if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, active or recent pancreatitis, severe gastrointestinal disorders that may be worsened by delayed gastric emptying, are pregnant, planning to become pregnant, or breastfeeding, or have severe kidney disease
Step 3: Medication Delivery Once prescribed, Klinic navigates the prior authorization process, ensuring your tirzepatide is delivered directly to your home
What sets Mounjaro apart is its unique dual-action mechanism, targeting two key hormone receptors in the body: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)
Dosage: The 400 mcg dosage aligns with common recommendations for women planning pregnancy and in early pregnancy.